我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

中药脑心多泰胶囊联合治疗阴虚阳亢型高血压病患者对颈动脉重构的效果

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2010年第3期
页码:
376-378,385
栏目:
临床研究
出版日期:
2010-04-06

文章信息/Info

Title:
Effect of naoxinduotai capsule on carotid artery remodeling in asthenic yin causing predominant yang symptom with primary hypertension in a randomized controlled trial
作者:
王国印1方邦江1杨建梅2章怡祎1顾仁樾3
上海中医药大学附属龙华医院:1.急救医学科,3.心内科,上海 200032;2.上海市徐汇区中心医院中医科,上海 200031
Author(s):
WANG Guo-yin1 FANG Bang-jang1 YANG Jian-mei2 ZHANG Yi-yi1 GU Ren-yue3
1.Department of Emergency Medicine, 3.Department of Cardiology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China; 2.Department of Traditional Chinese Medicine, Xujiahui Central Hospital, Shanghai 200031, China
关键词:
高血压病颈动脉重构阴虚阳亢证临床试验
Keywords:
primary hypertension vascular remodeling asthenic yin causing predominant yang symptom clinical trial
分类号:
R544.1
DOI:
-
文献标识码:
A
摘要:
目的: 观察中药脑心多泰胶囊治疗阴虚阳亢型高血压病患者对颈动脉重构的效果。方法: 采用随机对照临床试验观察阴虚阳亢型高血压病患者40例,脑心多泰胶囊加培哚普利治疗20例为联合治疗组,单用培哚普利治疗20例为对照组,疗程2月。采用日本Aloka 5500超声诊断仪,检测治疗前后压力应变弹性系数(EP)、硬化值(β)、顺应性(AC)、脉搏波传导速度(PWV),增大指数(AI)及双侧颈动脉内中膜厚度(IMT)等。观察治疗前后中医证候积分及颈动脉血管重构变化。结果: 联合治疗组中医证候积分呈明显下降趋势,疗效显著优于对照组(P<0.05)。联合治疗组EP,PWV,β均显著下降,AC显著提高,治疗前后差异有统计学意义(均P<0.05)。单用培哚普利组仅EP和PWV下降,治疗前后差异有统计学意义(P<0.05)。结论: 脑心多泰胶囊联合培哚普利明显改善高血压病患者临床症状,降低血管硬度,提高顺应性,疗效优于单用培哚普利。
Abstract:
AIM: To observe the effects of naoxinduotai capsule (active principles of tribulus terrestris) on carotid artery remodeling in a randomized controlled clinical trial. METHODS: A randomized controlled trial was designed. Forty patients of asthenic yin causing predominant yang with primary hypertension (PH) were divided into two groups (n=20 each): naoxinduotai capsule plus perindopril (trial group) and Perindopril group (control group). The patients' total of penthemeron integration syndrome, blood pressure, blood glucose, blood lipids and liver and kidney function were examined before and after treatment. Echo tracking ultrasonic parameters of carotid including pressure-strain elastic modulus (Ep), stiffness parameter (β), arterial compliance (AC), pulse wave velocity (PWV), augmentation index (AI), maximum vessel diameter, minimum vessel diameter, and intima media thickness (IMT) were obtained with echo tracking ultrasound technique. RESULTS: The sum of penthemeron integration syndrome had a statistically significant decreasing tendency after treatment, but the total in the trial group was statistically significantly lower than in the control group. EP, β and PWV decreased in a statistically significant manner and AC was statistically significantly increased in the trial group, whereas only statistically significantly decreased EP and PWV decreased in a statistically significant manner in the control group (P<0.05). CONCLUSION: Naoxinduotai capsule combined with perindopril shows better results in not only improving clinical symptoms of asthenic yin causing predominant yang symptom with PH, but also shows better results in inhibiting arotid artery stiffness and compliance degradation compared with perindopril alone.

参考文献/References

[1] 肖艳,邹旭,罗英. 痰瘀兼夹型高血压病与动脉粥样硬化的关系[J].中华实用中西医杂志, 2004, 17(15):2246-2247.

[2]李雅琴. 中西医结合治疗高血压颈动脉硬化38例观察[J]. 实用中医药杂志, 2004, 20(10):565.

[3]王健,余蓉,王洁婷,等. 化痰祛瘀片对颈动脉粥样硬化患者的疗效观察[J]. 广州中医药大学学报, 2004, 21(6):418-419.

[4] 翟丽华,董少红,李光展,等. 高血压病患者动态血压与颈动脉粥样硬化关系的研究[J]. 中国动脉硬化杂志, 2001, 9(2):143-145.

[5] Asmar RG, London GM, O’Rourke ME, et al. Improvement in blood pressure,arterial stiffness and wave refleclions with a very low dose perindopril/indapamide combinationin hypertension patient: a comparison with atenolol[J]. Hpertension, 2001, 38(4):922-926.

[6]肖沪生,银浩强,章怡祎,等. 应用新版eTRACKING技术对高血压患者颈动脉斑块的研究[J]. 上海医学影像, 2006, 15(2):87-89.

[7]蔡光先,朱克俭,韩育明,等. 高血压病常见证候临床流行病学观察[J]. 中医杂志, 1999, 40(8):4922-4931.

[8] 刘宇,顾仁樾,周端. 白蒺藜有效组分对兔和主动脉壁血小板生长因子-A基因表达的影响[J]. 中国中医基础医学杂志, 2001, 7(8):14-17.

[9]刘宇,顾仁樾,周端,等. 白蒺藜有效组分对兔动脉粥样硬化的实验研究[J]. 中华医药杂志, 2002, 2(10):865-867.

备注/Memo

备注/Memo:
收稿日期:2008-07-31.作者简介:王国印,主治医师,博士Email:g.y.wang@163.com
更新日期/Last Update: 2010-04-09